07:00 , Mar 31, 2016 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Dehydrosqualene desaturase (CrtN)

Infectious disease INDICATION: Staphylococcus In vitro, human blood and mouse studies identified a Naftin naftifine-derived CrtN inhibitor that could help treat methicillin-resistant Staphylococcus aureus (MRSA) infection. Chemical synthesis and testing of benzofuran analogs of Naftin...